405 related articles for article (PubMed ID: 21092237)
1. Impact of oral vitamin D supplementation on serum 25-hydroxyvitamin D levels in oncology.
Vashi PG; Trukova K; Lammersfeld CA; Braun DP; Gupta D
Nutr J; 2010 Nov; 9():60. PubMed ID: 21092237
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D Levels in Patients with Colorectal Cancer Before and After Treatment Initiation.
Savoie MB; Paciorek A; Zhang L; Van Blarigan EL; Sommovilla N; Abrams D; Atreya CE; Bergsland EK; Chern H; Kelley RK; Ko A; Laffan A; Sarin A; Varma MG; Venook AP; Van Loon K
J Gastrointest Cancer; 2019 Dec; 50(4):769-779. PubMed ID: 30058032
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D levels in Swiss breast cancer survivors.
Baumann M; Dani SU; Dietrich D; Hochstrasser A; Klingbiel D; Mark MT; Riesen WF; Ruhstaller T; Templeton AJ; Thürlimann B
Swiss Med Wkly; 2018; 148():w14576. PubMed ID: 29376548
[TBL] [Abstract][Full Text] [Related]
4. CYP2R1 polymorphisms are important modulators of circulating 25-hydroxyvitamin D levels in elderly females with vitamin insufficiency, but not of the response to vitamin D supplementation.
Arabi A; Khoueiry-Zgheib N; Awada Z; Mahfouz R; Al-Shaar L; Hoteit M; Rahme M; Baddoura R; Halabi G; Singh R; El Hajj Fuleihan G
Osteoporos Int; 2017 Jan; 28(1):279-290. PubMed ID: 27473187
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D status and per-oral vitamin D supplementation in patients suffering from chronic pancreatitis and pancreatic cancer disease.
Klapdor S; Richter E; Klapdor R
Anticancer Res; 2012 May; 32(5):1991-8. PubMed ID: 22593477
[TBL] [Abstract][Full Text] [Related]
6. Assessment of 3-epi-25-hydroxyvitamin D levels during cholecalciferol supplementation in adults with chronic liver diseases.
Stokes CS; Volmer DA
Appl Physiol Nutr Metab; 2016 Dec; 41(12):1311-1317. PubMed ID: 27863206
[TBL] [Abstract][Full Text] [Related]
7. Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer: The SUNSHINE Randomized Clinical Trial.
Ng K; Nimeiri HS; McCleary NJ; Abrams TA; Yurgelun MB; Cleary JM; Rubinson DA; Schrag D; Miksad R; Bullock AJ; Allen J; Zuckerman D; Chan E; Chan JA; Wolpin BM; Constantine M; Weckstein DJ; Faggen MA; Thomas CA; Kournioti C; Yuan C; Ganser C; Wilkinson B; Mackintosh C; Zheng H; Hollis BW; Meyerhardt JA; Fuchs CS
JAMA; 2019 Apr; 321(14):1370-1379. PubMed ID: 30964527
[TBL] [Abstract][Full Text] [Related]
8. Patients with Nonalcoholic Fatty Liver Disease Have a Low Response Rate to Vitamin D Supplementation.
Dasarathy J; Varghese R; Feldman A; Khiyami A; McCullough AJ; Dasarathy S
J Nutr; 2017 Oct; 147(10):1938-1946. PubMed ID: 28814531
[No Abstract] [Full Text] [Related]
9. Circulating vitamin D concentration and risk of seven cancers: Mendelian randomisation study.
Dimitrakopoulou VI; Tsilidis KK; Haycock PC; Dimou NL; Al-Dabhani K; Martin RM; Lewis SJ; Gunter MJ; Mondul A; Shui IM; Theodoratou E; Nimptsch K; Lindström S; Albanes D; Kühn T; Key TJ; Travis RC; Vimaleswaran KS; ; ; ; Kraft P; Pierce BL; Schildkraut JM
BMJ; 2017 Oct; 359():j4761. PubMed ID: 29089348
[No Abstract] [Full Text] [Related]
10. Effect of vitamin D3 seasonal supplementation with 1500 IU/day in north Italian children (DINOS study).
Mazzoleni S; Magni G; Toderini D
Ital J Pediatr; 2019 Jan; 45(1):18. PubMed ID: 30691521
[TBL] [Abstract][Full Text] [Related]
11. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
Wetmore JB; Kimber C; Mahnken JD; Stubbs JR
Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
[TBL] [Abstract][Full Text] [Related]
12. Serum 25-hydroxyvitamin D is inversely associated with body mass index in cancer.
Vashi PG; Lammersfeld CA; Braun DP; Gupta D
Nutr J; 2011 May; 10():51. PubMed ID: 21575232
[TBL] [Abstract][Full Text] [Related]
13. Effect of Vitamin D Supplementation on Relapse-Free Survival Among Patients With Digestive Tract Cancers: The AMATERASU Randomized Clinical Trial.
Urashima M; Ohdaira H; Akutsu T; Okada S; Yoshida M; Kitajima M; Suzuki Y
JAMA; 2019 Apr; 321(14):1361-1369. PubMed ID: 30964526
[TBL] [Abstract][Full Text] [Related]
14. Treatment with 50,000 IU vitamin D₂ every other week and effect on serum 25-hydroxyvitamin D₂, 25-hydroxyvitamin D₃, and total 25-hydroxyvitamin D in a clinical setting.
Demetriou ET; Travison TG; Holick MF
Endocr Pract; 2012; 18(3):399-402. PubMed ID: 22440989
[TBL] [Abstract][Full Text] [Related]
15. Effect of cholecalciferol recommended daily allowances on vitamin D status and fibroblast growth factor-23: an observational study in acute burn patients.
Rousseau AF; Damas P; Ledoux D; Cavalier E
Burns; 2014 Aug; 40(5):865-70. PubMed ID: 24462294
[TBL] [Abstract][Full Text] [Related]
16. Serum vitamin D metabolites in colorectal cancer patients receiving cholecalciferol supplementation: correlation with polymorphisms in the vitamin D genes.
Muindi JR; Adjei AA; Wu ZR; Olson I; Huang H; Groman A; Tian L; Singh PK; Sucheston LE; Johnson CS; Trump DL; Fakih MG
Horm Cancer; 2013 Aug; 4(4):242-50. PubMed ID: 23456391
[TBL] [Abstract][Full Text] [Related]
17. Baseline levels determine magnitude of increment in 25 hydroxy vitamin D following vitamin D3 prescription in healthy subjects.
Kaykhaei MA; Khodadoost M; Dashipour AR; Haidari Z; Karimkoshteh A; Sandoughi M
Endocrine; 2019 May; 64(2):378-383. PubMed ID: 30877526
[TBL] [Abstract][Full Text] [Related]
18. High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency.
von Restorff C; Bischoff-Ferrari HA; Theiler R
Bone; 2009 Oct; 45(4):747-9. PubMed ID: 19539796
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D deficiency is associated with functional decline and falls in frail elderly women despite supplementation.
Kotlarczyk MP; Perera S; Ferchak MA; Nace DA; Resnick NM; Greenspan SL
Osteoporos Int; 2017 Apr; 28(4):1347-1353. PubMed ID: 27975302
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D status in patients with stage IV colorectal cancer: findings from Intergroup trial N9741.
Ng K; Sargent DJ; Goldberg RM; Meyerhardt JA; Green EM; Pitot HC; Hollis BW; Pollak MN; Fuchs CS
J Clin Oncol; 2011 Apr; 29(12):1599-606. PubMed ID: 21422438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
